Shanghai Chest Hospital
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- -
- Established
- 1957-01-01
- Employees
- -
- Market Cap
- -
Comparison of Peri-procedural Complications of Intracardiac Echocardiography and Transesophageal Echocardiography in Patients With Atrial Fibrillation
Not Applicable
- Conditions
- Atrial Fibrillation
- Interventions
- Device: ICEDevice: TEE
- First Posted Date
- 2022-07-20
- Last Posted Date
- 2022-07-20
- Lead Sponsor
- Shanghai Chest Hospital
- Target Recruit Count
- 1200
- Registration Number
- NCT05466266
Sintilimab Combined With Anlotinib for Perioperative Non-small Cell Lung Cancer Based on MRD Evaluation
Phase 2
Recruiting
- Conditions
- Minimal Residual DiseaseAnti-angiogenesisNon-small Cell Lung CancerImmunotherapy
- Interventions
- First Posted Date
- 2022-07-15
- Last Posted Date
- 2022-07-15
- Lead Sponsor
- Shanghai Chest Hospital
- Target Recruit Count
- 42
- Registration Number
- NCT05460195
- Locations
- 🇨🇳
Shanghai Chest Hospital, Shanghai, China
CARTO-Finder Guided Ablation Versus Multiscale Entropy Guided Ablation in Persistent Atrial Fibrillation
Not Applicable
Not yet recruiting
- Conditions
- Persistent Atrial Fibrillation
- Interventions
- Procedure: CARTO-Finder-guided ablation plus PVIProcedure: Multiscale entropy-guided ablation plus PVI
- First Posted Date
- 2022-07-12
- Last Posted Date
- 2022-07-12
- Lead Sponsor
- Shanghai Chest Hospital
- Target Recruit Count
- 200
- Registration Number
- NCT05454111
- Locations
- 🇨🇳
Shanghai Chest Hospital, Shanghai, China
First-line Treatment With Dacomitinib Plus Anlotinib for Patients With Advanced NSCLC With EGFR 21L858R Mutations
Phase 1
Recruiting
- Conditions
- Non-Small Cell Lung Cancer (NSCLC)
- Interventions
- Drug: Dacomitinib+Anlotinib
- First Posted Date
- 2022-03-09
- Last Posted Date
- 2023-04-19
- Lead Sponsor
- Shanghai Chest Hospital
- Target Recruit Count
- 140
- Registration Number
- NCT05271916
- Locations
- 🇨🇳
Shanghai Chest Hospital, Shanghai, Shanghai, China
Adjunctive Right Atrial Ablation for Persistent Atrial Fibrillation With Right Atrial Enlargement
Completed
- Conditions
- Persistent Atrial FibrillationRight Atrial Enlargement
- Interventions
- Procedure: Circumferential pulmonary vein isolation + linear ablation + bi-atrial mapping + left atrial driver ablation + right atrial driver ablationProcedure: Circumferential pulmonary vein isolation + linear ablation + bi-atrial mapping + left atrial driver ablation
- First Posted Date
- 2022-02-07
- Last Posted Date
- 2022-02-07
- Lead Sponsor
- Shanghai Chest Hospital
- Target Recruit Count
- 195
- Registration Number
- NCT05227586
- Locations
- 🇨🇳
Mu Qin, Shanghai, China
Exosomes Detection for the Prediction of the Efficacy and Adverse Reactions of Anlotinib in Patients With Advanced NSCLC
- First Posted Date
- 2022-02-01
- Last Posted Date
- 2022-02-01
- Lead Sponsor
- Shanghai Chest Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT05218759
SHR-1701 for Consolidation Therapy After Concurrent Chemoradiotherapy in Inoperable Stage III NSCLC
- First Posted Date
- 2022-01-04
- Last Posted Date
- 2022-01-04
- Lead Sponsor
- Shanghai Chest Hospital
- Target Recruit Count
- 19
- Registration Number
- NCT05177497
Left Atrial Isolation by Catheter Ablation in Persistent Atrial Fibrillation With Severe Atrial Fibrosis
Not Applicable
Not yet recruiting
- Conditions
- Persistent Atrial Fibrillation
- Interventions
- Procedure: Left atrial isolation by catheter ablation
- First Posted Date
- 2021-12-30
- Last Posted Date
- 2022-08-10
- Lead Sponsor
- Shanghai Chest Hospital
- Target Recruit Count
- 50
- Registration Number
- NCT05173779
Augmented Reality-assisted Localization of Solitary Pulmonary Nodules for Precise Sublobar Lung Resection
Not Applicable
- Conditions
- SPNLung Cancer
- Interventions
- Device: Augmented Reality-assisted localization of solitary pulmonary nodule
- First Posted Date
- 2021-12-17
- Last Posted Date
- 2021-12-17
- Lead Sponsor
- Shanghai Chest Hospital
- Target Recruit Count
- 20
- Registration Number
- NCT05162235
Catheter Ablation and Surgical Ablation of Persistent Atrial Fibrillation With Severe Atrial Fibrosis
Not Applicable
Not yet recruiting
- Conditions
- Persistent Atrial Fibrillation
- Interventions
- Procedure: Surgical ablationProcedure: Circumferential pulmonary vein isolation + linear ablation + bi-atrial mapping + driver ablationProcedure: Circumferential pulmonary vein isolation + linear ablation + vein of Marshall ethanol infusion
- First Posted Date
- 2021-12-10
- Last Posted Date
- 2021-12-10
- Lead Sponsor
- Shanghai Chest Hospital
- Target Recruit Count
- 300
- Registration Number
- NCT05153486
© Copyright 2025. All Rights Reserved by MedPath